NEW YORK (360Dx) –In several peer-reviewed publications led by researchers at the University of Pennsylvania's Perleman School of Medicine, T2 Biosystems' magnetic resonance technology has shown the ability to offer new insights into hemostasis, the process by which the body stops bleeding.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.